DiaSorin SpA (DIA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:DiaSorin SpA (DIA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7083
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

DiaSorin SpA (DIA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaSorin SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaSorin SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DiaSorin SpA, Medical Equipment, Deal Details 10
Asset Purchase 10
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 10
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 11
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million 13
Partnerships 14
Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology 14
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 15
DiaSorin Enters into Agreement with Tecan 16
DiaSorin Enters into Agreement with QIAGEN 17
DiaSorin Enters into Agreement with Beckman Coulter 18
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 19
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin 20
DiaSorin Forms Joint Venture With Trivitron Healthcare 21
Asset Transactions 22
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 22
DiaSorin SpA – Key Competitors 24
DiaSorin SpA – Key Employees 25
DiaSorin SpA – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Aug 02, 2018: The Board of Directors approves the results for the first half of 2018 28
May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 32
Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 35
Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 36
May 08, 2017: Diasorin Group Reports Growth In Revenues And Profitability In The First Quarter 2017, Generating A Relevant Free Cash Flow 39
Mar 08, 2017: Net Profit And Cash Generation Reached Record Highs In 2016, Driven By Growth In Revenues And Profitability 41
Product News 44
Jun 12, 2018: Diasorin Introduces Primer Pair Reagents For Use In Molecular Testing: Anaplasma Phagocytophilum, Ehrlichia And Babesia 44
Jun 12, 2018: DiaSorin Molecular Introduces Primer Pair Reagents for A. phagocytophilum, Ehrlichia and Babesia 45
Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus 46
Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus 47
Other Significant Developments 48
Jun 26, 2017: Diasorin Presents Its 2017-2019 Industrial Plan 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
DiaSorin SpA, Medical Equipment, Key Facts, 2017 2
DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaSorin SpA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaSorin SpA, Deals By Market, 2012 to YTD 2018 8
DiaSorin SpA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million 10
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 11
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million 13
Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology 14
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies 15
DiaSorin Enters into Agreement with Tecan 16
DiaSorin Enters into Agreement with QIAGEN 17
DiaSorin Enters into Agreement with Beckman Coulter 18
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics 19
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin 20
DiaSorin Forms Joint Venture With Trivitron Healthcare 21
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics 22
DiaSorin SpA, Key Competitors 24
DiaSorin SpA, Key Employees 25
DiaSorin SpA, Other Locations 26
DiaSorin SpA, Subsidiaries 26

List of Figures
DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
DiaSorin SpA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
DiaSorin SpA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
DiaSorin SpA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
DiaSorin SpA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[DiaSorin SpA (DIA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sisaf Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Hedberg Landscape & Masonry Supplies:企業の戦略的SWOT分析
    Hedberg Landscape & Masonry Supplies - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Ajinomoto Co., Inc.:企業の戦略・SWOT・財務情報
    Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Ajinomoto Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • HORNBACH Holding AG & Co. KGaA:企業の戦略・SWOT・財務情報
    HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary HORNBACH Holding AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nevada Gold & Casinos, Inc.:企業の戦略・SWOT・財務分析
    Nevada Gold & Casinos, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nevada Gold & Casinos, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Grupo Ferrer Internacional SA:企業の戦略・SWOT・財務情報
    Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Ferrer Internacional SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Ache Laboratorios Farmaceuticos SA-製薬・医療分野:企業M&A・提携分析
    Summary Ache Laboratorios Farmaceuticos SA (Ache) is a drug company that offers generic products. The company provides prescription, prescription free, generic, dermatological, dermocosmetic drugs, nutraceuticals and probiotic products. Its activities include research, development, production, distr …
  • Open Text Corporation:企業のM&A・事業提携・投資動向
    Open Text Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Open Text Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Raley’s Family of Fine Stores:企業の戦略的SWOT分析
    Raley's Family of Fine Stores - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • ATS Automation Tooling Systems Inc (ATA):企業の財務・戦略的SWOT分析
    ATS Automation Tooling Systems Inc (ATA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • JX Nippon Oil & Gas Exploration Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    JX Nippon Oil & Gas Exploration Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary JX Nippon Oil & Gas Exploration Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that o …
  • Crystal Rock Holdings, Inc:企業の戦略・SWOT・財務情報
    Crystal Rock Holdings, Inc - Strategy, SWOT and Corporate Finance Report Summary Crystal Rock Holdings, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products comprise pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal disorders. Its pipeline pro …
  • Cellmid Ltd (CDY):医療機器:M&Aディール及び事業提携情報
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Thermo Fisher Scientific Inc (TMO):企業の財務・戦略的SWOT分析
    Thermo Fisher Scientific Inc (TMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Miracor Medical Systems GmbH:製品パイプライン分析
    Summary Miracor Medical Systems GmbH (Miracor Medical) is a medical device company that develops and commercializes pressure-controlled intermittent coronary sinus occlusions. The company offers products for continuous monitoring of coronary sinus pressure dynamics. It offers impulse console and imp …
  • Eppendorf AG:医療機器:M&Aディール及び事業提携情報
    Summary Eppendorf AG (Eppendorf) is a life science company that develops, manufactures and sells equipment as well as offers services for handling liquids, samples and cells in laboratories. Its product portfolio includes pipettes, automated pipetting systems, spectrometers, centrifuges, mixers, dis …
  • Sakai Chemical Industry Co Ltd (4078):企業の財務・戦略的SWOT分析
    Sakai Chemical Industry Co Ltd (4078) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Komeri Co Ltd:企業の戦略・SWOT・財務情報
    Komeri Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Komeri Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Spark Infrastructure Group:発電所・企業SWOT分析
    Spark Infrastructure Group - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆